Avian influenza viruses, inflammation, and CD8+ T cell immunity

Frontiers in Immunology

Volumn 7, Issue MAR, 2016, Pages

  Wang, Zhongfang ^a   Loh, Liyen ^a   Kedzierski, Lukasz ^a   Kedzierska, Katherine ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Avian influenza virus; CD8+ T cells; Human; Inflammation; Influenza; Influenza disease

Indexed keywords

ANTIBIOTIC AGENT; INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR;

AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DISEASE SEVERITY; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INFLUENZA A VIRUS (H10N8); INFLUENZA A VIRUS (H5N1); INFLUENZA A VIRUS (H7N2); INFLUENZA A VIRUS (H7N9); INFLUENZA A VIRUS (H9N2); NONHUMAN; PANDEMIC INFLUENZA; PREVALENCE; REVIEW; VIRUS LOAD; VIRUS TRANSMISSION; VIRUS VIRULENCE;

EID: 84964663219     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00060     Document Type: Review

References (126)

1. Peiris JS, de Jong MD, Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev (2007) 20(2):243-67. doi: 10.1128/CMR.00037-06
2. Shi Y, Wu Y, Zhang W, Qi J, Gao GF. Enabling the 'host jump': structural determinants of receptor-binding specificity in influenza A viruses. Nat Rev Microbiol (2014) 12(12):822-31. doi:10.1038/nrmicro3362
3. Alexander DJ. An overview of the epidemiology of avian influenza. Vaccine (2007) 25(30):5637-44. doi:10.1016/j.vaccine.2006.10.051
4. Alexander DJ. A review of avian influenza in different bird species. Vet Microbiol (2000) 74(1-2):3-13. doi:10.1016/S0378-1135(00)00160-7
5. Ostrowsky B, Huang A, Terry W, Anton D, Brunagel B, Traynor L, et al. Low pathogenic avian influenza A (H7N2) virus infection in immunocompromised adult, New York, USA, 2003. Emerg Infect Dis (2012) 18(7):1128-31. doi:10.3201/eid1807.111913
6. Centers for Disease Control and Prevention. Notes from the field: highly pathogenic avian influenza A (H7N3) virus infection in two poultry workers-Jalisco, Mexico, July 2012. MMWR Morb Mortal Wkly Rep (2012) 61(36):726-7.
7. Skowronski DM, Tweed SA, Petric M, Booth T, Li Y, Tam T. Human illness and isolation of low-pathogenicity avian influenza virus of the H7N3 subtype in British Columbia, Canada. J Infect Dis (2006) 193(6):899-900;authorrely900. doi:10.1086/500219
8. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A (2004) 101(5):1356-61. doi:10.1073/pnas.0308352100
9. Puzelli S, Rossini G, Facchini M, Vaccari G, Di Trani L, Di Martino A, et al. Human infection with highly pathogenic A(H7N7) avian influenza virus, Italy, 2013. Emerg Infect Dis (2014) 20(10):1745-9. doi:10.3201/eid2010.140512
10. Capua I, Alexander DJ. Avian influenza and human health. Acta Trop (2002) 83(1):1-6. doi:10.1016/S0001-706X(02)00050-5
11. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med (2013) 368(20):1888-97. doi:10.1056/NEJMoa1304459
12. Yang ZF, Mok CK, Peiris JS, Zhong NS. Human infection with a novel avian influenza A(H5N6) virus. N Engl J Med (2015) 373(5):487-9. doi:10.1056/NEJMc1502983
13. Wei SH, Yang JR, Wu HS, Chang MC, Lin JS, Lin CY, et al. Human infection with avian influenza A H6N1 virus: an epidemiological analysis. Lancet Respir Med (2013) 1(10):771-8. doi:10.1016/S2213-2600(13)70221-2
14. Avian Influenza Virus A(H10N7) Circulating Among Humans in Egypt. Pan American Health Organization PAHO. (2004). Available from: http://new.paho.org/hq/dmdocuments/2010/Avian_Influenza_Egypt_070503.pdf
15. Arzey GG, Kirkland PD, Arzey KE, Frost M, Maywood P, Conaty S, et al. Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia. Emerg Infect Dis (2012) 18(5):814-6. doi:10.3201/eid1805.111852
16. Liu M, Li X, Yuan H, Zhou J, Wu J, Bo H, et al. Genetic diversity of avian influenza A (H10N8) virus in live poultry markets and its association with human infections in China. Sci Rep (2015) 5:7632. doi:10.1038/srep07632
17. Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen V, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med (2004) 350(12):1179-88. doi:10.1056/NEJMoa040419
18. de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med (2005) 352(7):686-91. doi:10.1056/NEJMoa044307
19. Hien TT, de Jong M, Farrar J. Avian influenza-a challenge to global health care structures. N Engl J Med (2004) 351(23):2363-5. doi:10.1056/NEJMp048267
20. Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet (2013) 381(9881):1916-25. doi:10.1016/S0140-6736(13)60903-4
21. Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol (1999) 37(4):937-43.
22. Wang Z, Wan Y, Qiu C, Quinones-Parra S, Zhu Z, Loh L, et al. Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8(+) T cells. Nat Commun (2015) 6:6833. doi:10.1038/ncomms7833
23. Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med (2005) 352(4):333-40. doi:10.1056/NEJMoa044021
24. Li FC, Choi BC, Sly T, Pak AW. Finding the real case-fatality rate of H5N1 avian influenza. J Epidemiol Community Health (2008) 62(6):555-9. doi:10.1136/jech.2007.064030
25. Su S, Bi Y, Wong G, Gray GC, Gao GF, Li S. Epidemiology, evolution, and recent outbreaks of avian influenza virus in China. J Virol (2015) 89(17):8671-6. doi:10.1128/JVI.01034-15
26. Pan M, Gao R, Lv Q, Huang S, Zhou Z, Yang L, et al. Human infection with a novel highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings. J Infect (2015) 72(1):52-9. doi:10.1016/j.jinf.2015.06.009
27. Centers for Disease Control and Prevention. Isolation of avian influenza A(H5N1) viruses from humans-Hong Kong, May-December 1997. MMWR Morb Mortal Wkly Rep (1997) 46(50):1204-7.
28. Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet (2004) 363(9409):617-9. doi:10.1016/S0140-6736(04)15595-5
29. Zhu QY, Qin ED, Wang W, Yu J, Liu BH, Hu Y, et al. Fatal infection with influenza A (H5N1) virus in China. N Engl J Med (2006) 354(25):2731-2. doi:10.1056/NEJMc066058
30. Peiris JS. Avian influenza viruses in humans. Rev Sci Tech OffInt Epiz (2009) 28(1):161-74.
31. E. Team. Avian influenza A/(H7N2) outbreak in the United Kingdom. Euro Surveill (2007) 12(22):3206.
32. Tweed SA, Skowronski DM, David ST, Larder A, Petric M, Lees W, et al. Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis (2004) 10(12):2196-9. doi:10.3201/eid1012.040961
33. Nguyen-Van-Tam JS, Nair P, Acheson P, Baker A, Barker M, Bracebridge S, et al. Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill (2006) 11(5):E0605042.
34. Notes from the Field. Highly pathogenic avian influenza A (H7N3) virus infection in two poultry workers-Jalisco, Mexico, July 2012. MMWR Morb Mortal Wkly Rep (2012) 61(36):726-7.
35. Webster RG, Geraci J, Petursson G, Skirnisson K. Conjunctivitis in human beings caused by influenza A virus of seals. N Engl J Med (1981) 304(15):911. doi:10.1056/NEJM198104093041515
36. Kurtz J, Manvell RJ, Banks J. Avian influenza virus isolated from a woman with conjunctivitis. Lancet (1996) 348(9031):901-2. doi:10.1016/S0140-6736(05)64783-6
37. Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, Vennema H, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet (2004) 363(9409):587-93. doi:10.1016/S0140-6736(04)15589-X
38. Guo Y, Li J, Cheng X. [Discovery of men infected by avian influenza A (H9N2) virus]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi (1999) 13(2):105-8.
39. Peiris M, Yuen KY, Leung CW, Chan KH, Ip PL, Lai RW, et al. Human infection with influenza H9N2. Lancet (1999) 354(9182):916-7. doi:10.1016/S0140-6736(99)03311-5
40. Butt KM, Smith GJ, Chen H, Zhang LJ, Leung YH, Xu KM, et al. Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J Clin Microbiol (2005) 43(11):5760-7. doi:10.1128/JCM.43.11.5760-5767.2005
41. Cheng VC, Chan JF, Wen X, Wu WL, Que TL, Chen H, et al. Infection of immunocompromised patients by avian H9N2 influenza A virus. J Infect (2011) 62(5):394-9. doi:10.1016/j.jinf.2011.02.007
42. International Centre for Diarrhoeal Disease Research, Bangladesh/Government of The People's Republic of Bangladesh, Outbreak of mild respiratory disease caused by H5N1 and H9N2 infections among young children in Dhaka, Bangladesh, 2011. HSB (2011) 9(2):5-12.
43. Barclay WS, Zambon M. Pandemic risks from bird flu. BMJ (2004) 328(7434):238-9. doi:10.1136/bmj.328.7434.238
44. Monto AS. The threat of an avian influenza pandemic. N Engl J Med (2005) 352(4):323-5. doi:10.1056/NEJMp048343
45. Van Reeth K. Avian and swine influenza viruses: our current understanding of the zoonotic risk. Vet Res (2007) 38(2):243-60. doi:10.1051/vetres:2006062
46. Li Q, Zhou L, Zhou M, Chen Z, Li F, Wu H, et al. Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med (2014) 370(6):520-32. doi:10.1056/NEJMoa1304617
47. Taubenberger JK, Morens DM. Influenza revisited. Emerg Infect Dis (2006) 12(1):1-2. doi:10.3201/eid1201.051442
48. Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis (2006) 12(1):15-22. doi:10.3201/eid1209.05-0979
49. Ma C, Lam TT, Chai Y, Wang J, Fan X, Hong W, et al. Emergence and evolution of H10 subtype influenza viruses in poultry in China. J Virol (2015) 89(7):3534-41. doi:10.1128/JVI.03167-14
50. Pu J, Wang S, Yin Y, Zhang G, Carter RA, Wang J, et al. Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus. Proc Natl Acad Sci U S A (2015) 112(2):548-53. doi:10.1073/pnas.1422456112
51. Yu L, Wang Z, Chen Y, Ding W, Jia H, Chan JF, et al. Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus. Clin Infect Dis (2013) 57(10):1449-57. doi:10.1093/cid/cit541
52. Bi Y, Lu L, Li J, Yin Y, Zhang Y, Gao H, et al. Novel genetic reassortants in H9N2 influenza A viruses and their diverse pathogenicity to mice. Virol J (2011) 8:505. doi:10.1186/1743-422X-8-505
53. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep (2010) 59:1-62.
54. WER Wkly Epidemiol Rec (2008) 83(46):413-20.
55. Arima Y, Vong S, World Health Organization Outbreak Response Team. Human infections with avian influenza A(H7N9) virus in China: preliminary assessments of the age and sex distribution. Western Pac Surveill Response J (2013) 4(2):1-3. doi:10.5365/wpsar.2013.4.2.005
56. Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nat Immunol (2013) 14(5):428-36. doi:10.1038/ni.2588
57. Shaw AC, Goldstein DR, Montgomery RR. Age-dependent dysregulation of innate immunity. Nat Rev Immunol (2013) 13(12):875-87. doi:10.1038/nri3547
58. Zhu Z, Liu Y, Xu L, Guan W, Zhang X, Qi T, et al. Extra-pulmonary viral shedding in H7N9 Avian Influenza patients. J Clin Virol (2015) 69:30-2. doi:10.1016/j.jcv.2015.05.013
59. Hu Y, Lu S, Song Z, Wang W, Hao P, Li J, et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet (2013) 381(9885):2273-9. doi:10.1016/S0140-6736(13)61125-3
60. Uiprasertkul M, Kitphati R, Puthavathana P, Kriwong R, Kongchanagul A, Ungchusak K, et al. Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerg Infect Dis (2007) 13(5):708-12. doi:10.3201/eid1305.060572
61. Zhang Z, Zhang J, Huang K, Li KS, Yuen KY, Guan Y, et al. Systemic infection of avian influenza A virus H5N1 subtype in humans. Hum Pathol (2009) 40(5):735-9. doi:10.1016/j.humpath.2008.08.015
62. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus, Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med (2008) 358(3):261-73. doi:10.1056/NEJMra0707279
63. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med (2006) 12(10):1203-7. doi:10.1038/nm1477
64. Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med (2013) 368(24):2277-85. doi:10.1056/NEJMoa1305584
65. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, et al. of the World Health Organization consultation on human influenza: avian influenza A (H5N1) infection in humans. N Engl J Med (2005) 353(13):1374-85. doi:10.1056/NEJMra052211
66. Brundage JF, Shanks GD. Deaths from bacterial pneumonia during 1918-19 influenza pandemic. Emerg Infect Dis (2008) 14(8):1193-9. doi:10.3201/eid1408.071313
67. Yu X, Zhang X, He Y, Wu H, Gao X, Pan Q, et al. Mild infection of a novel H7N9 avian influenza virus in children in Shanghai. Emerg Microbes Infect (2013) 2(7):e41. doi:10.1038/emi.2013.41
68. Guo J, Huang F, Liu J, Chen Y, Wang W, Cao B, et al. The serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes. Sci Rep (2015) 5:10942. doi:10.1038/srep10942
69. Wang Z, Zhang A, Wan Y, Liu X, Qiu C, Xi X, et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci U S A (2014) 111(2):769-74. doi:10.1073/pnas.1321748111
70. Chan MC, Cheung CY, Chui WH, Tsao SW, Nicholls JM, Chan YO, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res (2005) 6:135. doi:10.1186/1465-9921-6-135
71. Zeng H, Belser JA, Goldsmith CS, Gustin KM, Veguilla V, Katz JM, et al. A(H7N9) virus results in early induction of proinflammatory cytokine responses in both human lung epithelial and endothelial cells and shows increased human adaptation compared with avian H5N1 virus. J Virol (2015) 89(8):4655-67. doi:10.1128/JVI.03095-14
72. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, Garcia-Sastre A, et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci U S A (2009) 106(9):3455-60. doi:10.1073/pnas.0813234106
73. Govorkova EA, Rehg JE, Krauss S, Yen HL, Guan Y, Peiris M, et al. Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J Virol (2005) 79(4):2191-8. doi:10.1128/JVI.79.4.2191-2198.2005
74. Tumpey TM, Lu X, Morken T, Zaki SR, Katz JM. Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol (2000) 74(13):6105-16. doi:10.1128/JVI.74.13.6105-6116.2000
75. Zitzow LA, Rowe T, Morken T, Shieh WJ, Zaki S, Katz JM. Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J Virol (2002) 76(9):4420-9. doi:10.1128/JVI.76.9.4420-4429.2002
76. Belser JA, Zeng H, Katz JM, Tumpey TM. Infection with highly pathogenic H7 influenza viruses results in an attenuated proinflammatory cytokine and chemokine response early after infection. J Infect Dis (2011) 203(1):40-8. doi:10.1093/infdis/jiq018
77. Zeng H, Goldsmith C, Thawatsupha P, Chittaganpitch M, Waicharoen S, Zaki S, et al. Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type I interferon response in polarized human bronchial epithelial cells. J Virol (2007) 81(22):12439-49. doi:10.1128/JVI.01134-07
78. Salomon R, Hoffmann E, Webster RG. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci U S A (2007) 104(30):12479-81. doi:10.1073/pnas.0705289104
79. Kuchipudi SV, Tellabati M, Sebastian S, Londt BZ, Jansen C, Vervelde L, et al. Highly pathogenic avian influenza virus infection in chickens but not ducks is associated with elevated host immune and pro-inflammatory responses. Vet Res (2014) 45:118. doi:10.1186/s13567-014-0118-3
80. Barber MR, Aldridge JR Jr, Webster RG, Magor KE. Association of RIG-I with innate immunity of ducks to influenza. Proc Natl Acad Sci U S A (2010) 107(13):5913-8. doi:10.1073/pnas.1001755107
81. Nakajima N, Van Tin N, Sato Y, Thach HN, Katano H, Diep PH, et al. Pathological study of archival lung tissues from five fatal cases of avian H5N1 influenza in Vietnam. Mod Pathol (2013) 26(3):357-69. doi:10.1038/modpathol.2012.193
82. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet (2002) 360(9348):1831-7. doi:10.1016/S0140-6736(02)11772-7
83. Sakabe S, Iwatsuki-Horimoto K, Takano R, Nidom CA, Le M, Nagamura-Inoue T, et al. Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses. J Gen Virol (2011) 92(Pt 6):1428-34. doi:10.1099/vir.0.030346-0
84. Friesenhagen J, Boergeling Y, Hrincius E, Ludwig S, Roth J, Viemann D. Highly pathogenic avian influenza viruses inhibit effective immune responses of human blood-derived macrophages. J Leukoc Biol (2012) 92(1):11-20. doi:10.1189/jlb.0911479
85. van Riel D, Leijten LM, van der Eerden M, Hoogsteden HC, Boven LA, Lambrecht BN, et al. Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha induction. PLoS Pathog (2011) 7(6):e1002099. doi:10.1371/journal.ppat.1002099
86. Chan MC, Chan RW, Chan LL, Mok CK, Hui KP, Fong JH, et al. Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract. Lancet Respir Med (2013) 1(7):534-42. doi:10.1016/S2213-2600(13)70138-3
87. Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol (2013) 14(10):986-95. doi:10.1038/ni.2705
88. Italiani P, Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol (2014) 5:514. doi:10.3389/fimmu.2014.00514
89. Jegaskanda S, Reading PC, Kent SJ. Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine. J Immunol (2014) 193(2):469-75. doi:10.4049/jimmunol.1400432
90. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol (2001) 19:197-223. doi:10.1146/annurev.immunol.19.1.197
91. Parham P, Norman PJ, Abi-Rached L, Guethlein LA. Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Philos Trans R Soc Lond B Biol Sci (2012) 367(1590):800-11. doi:10.1098/rstb.2011.0266
92. Terajima M, Co MD, Cruz J, Ennis FA. High antibody-dependent cellular cytotoxicity antibody titers to H5N1 and H7N9 avian influenza A viruses in healthy US adults and older children. J Infect Dis (2015) 212(7):1052-60. doi:10.1093/infdis/jiv181
93. Dusseaux M, Martin E, Serriari N, Peguillet I, Premel V, Louis D, et al. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood (2011) 117(4):1250-9. doi:10.1182/blood-2010-08-303339
94. Hazenberg MD, Spits H. Human innate lymphoid cells. Blood (2014) 124(5):700-9. doi:10.1182/blood-2013-11-427781
95. Tang XZ, Jo J, Tan AT, Sandalova E, Chia A, Tan KC, et al. IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells. J Immunol (2013) 190(7):3142-52. doi:10.4049/jimmunol.1203218
96. Chan AC, Leeansyah E, Cochrane A, d'Udekem d'Acoz Y, Mittag D, Harrison LC, et al. Ex-vivo analysis of human natural killer T cells demonstrates heterogeneity between tissues and within established CD4(+) and CD4(-) subsets. Clin Exp Immunol (2013) 172(1):129-37. doi:10.1111/cei.12045
97. Paget C, Ivanov S, Fontaine J, Renneson J, Blanc F, Pichavant M, et al. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J Biol Chem (2012) 287(12):8816-29. doi:10.1074/jbc. M111.304758
98. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol (2011) 12(11):1045-54. doi:10.1031/ni.2131
99. Qin G, Mao H, Zheng J, Sia SF, Liu Y, Chan PL, et al. Phosphoantigen-expanded human gammadelta T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses. J Infect Dis (2009) 200(6):858-65. doi:10.1086/605413
100. McMichael AJ, Gotch FM, Dongworth DW, Clark A, Potter CW. Declining T-cell immunity to influenza, 1977-82. Lancet (1983) 2(8353):762-4. doi:10.1016/S0140-6736(83)92297-3
101. Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, Carman W, et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med (2013) 19(10):1305-12. doi:10.1038/nm.3350
102. Hayward AC, Wang L, Goonetilleke N, Fragaszy EB, Bermingham A, Copas A, et al. Natural T cell-mediated protection against seasonal and pandemic influenza. Results of the Flu Watch Cohort Study. Am J Respir Crit Care Med (2015) 191(12):1422-31. doi:10.1164/rccm.201411-1988OC
103. Thomas PG, Keating R, Hulse-Post DJ, Doherty PC. Cell-mediated protection in influenza infection. Emerg Infect Dis (2006) 12(1):48-54. doi:10.3201/eid1201.051237
104. Kedzierska K, La Gruta NL, Turner SJ, Doherty PC. Establishment and recall of CD8+ T-cell memory in a model of localized transient infection. Immunol Rev (2006) 211:133-45. doi:10.1111/j.0105-2896.2006.00386.x
105. Kedzierski L, Linossi EM, Kolesnik TB, Day EB, Bird NL, Kile BT, et al. Suppressor of cytokine signaling 4 (SOCS4) protects against severe cytokine storm and enhances viral clearance during influenza infection. PLoS Pathog (2014) 10(5):e1004134. doi:10.1371/journal.ppat.1004134
106. Bird NL, Olson MR, Hurt AC, Oshansky CM, Oh DY, Reading PC, et al. Oseltamivir prophylaxis reduces inflammation and facilitates establishment of cross-strain protective T cell memory to influenza viruses. PLoS One (2015) 10(6):e0129768. doi:10.1371/journal.pone.0129768
107. Kedzierska K, Guillonneau C, Gras S, Hatton LA, Webby R, Purcell AW, et al. Complete modification of TCR specificity and repertoire selection does not perturb a CD8+ T cell immunodominance hierarchy. Proc Natl Acad Sci U S A (2008) 105(49):19408-13. doi:10.1073/pnas.0810274105
108. Hatta M, Hatta Y, Kim JH, Watanabe S, Shinya K, Nguyen T, et al. Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog (2007) 3(10):1374-9. doi:10.1371/journal.ppat.0030133
109. Bao L, Xu L, Zhu H, Deng W, Chen T, Lv Q, et al. Transmission of H7N9 influenza virus in mice by different infective routes. Virol J (2014) 11:185. doi:10.1186/1743-422X-11-185
110. Mok CK, Lee HH, Chan MC, Sia SF, Lestra M, Nicholls JM, et al. Pathogenicity of the novel A/H7N9 influenza virus in mice. MBio (2013) 4(4):e00362-13. doi:10.1128/mBio.00362-13
111. Duan S, Meliopoulos VA, McClaren JL, Guo XZ, Sanders CJ, Smallwood HS, et al. Diverse heterologous primary infections radically alter immunodominance hierarchies and clinical outcomes following H7N9 influenza challenge in mice. PLoS Pathog (2015) 11(2):e1004642. doi:10.1371/journal.ppat.1004642
112. Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC, et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med (2012) 18(2):274-80. doi:10.1038/nm.2612
113. Epstein SL. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis (2006) 193(1):49-53. doi:10.1086/498980
114. Wright P, Webster R. Orthomyxoviruses. Philadelphia: Lippincott Williams & Wilkins (2001).
115. Hillaire ML, van Trierum SE, Bodewes R, van Baalen CA, van Binnendijk RS, Koopmans MP, et al. Characterization of the human CD8(+) T cell response following infection with 2009 pandemic influenza H1N1 virus. J Virol (2011) 85(22):12057-61. doi:10.1128/JVI.05204-11
116. Miao H, Hollenbaugh JA, Zand MS, Holden-Wiltse J, Mosmann TR, Perelson AS, et al. Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus. J Virol (2010) 84(13):6687-98. doi:10.1128/JVI.00266-10
117. Ennis FA, Rook AH, Qi YH, Schild GC, Riley D, Pratt R, et al. HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines. Lancet (1981) 2(8252):887-91. doi:10.1016/S0140-6736(81)91389-1
118. Wagar LE, Rosella L, Crowcroft N, Lowcock B, Drohomyrecky PC, Foisy J, et al. Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination. PLoS One (2011) 6(11):e28063. doi:10.1371/journal.pone.0028063
119. Jameson J, Cruz J, Terajima M, Ennis FA. Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species. J Immunol (1999) 162(12):7578-83.
120. Goy K, Von Bibra S, Lewis J, Laurie K, Barr I, Anderson D, et al. Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza. Influenza Other Respir Viruses (2008) 2(4):115-25. doi:10.1111/j.1750-2659.2008.00046.x
121. Kreijtz JH, de Mutsert G, van Baalen CA, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol (2008) 82(11):5161-6. doi:10.1128/JVI.02694-07
122. Lee LY, Ha do LA, Simmons C, de Jong MD, Chau NV, Schumacher R, et al. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest (2008) 118(10):3478-90. doi:10.1172/JCI32460
123. van de Sandt CE, Kreijtz JH, de Mutsert G, Geelhoed-Mieras MM, Hillaire ML, Vogelzang-van Trierum SE, et al. Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus. J Virol (2014) 88(3):1684-93. doi:10.1128/JVI.02843-13
124. Quinones-Parra S, Grant E, Loh L, Nguyen TH, Campbell KA, Tong SY, et al. Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicities. Proc Natl Acad Sci U S A (2014) 111(3):1049-54. doi:10.1073/pnas.1322229111
125. Kedzierska K, Turner SJ, Doherty PC. Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope. Proc Natl Acad Sci U S A (2004) 101(14):4942-7. doi:10.1073/pnas.0401279101
126. Marshall DR, Turner SJ, Belz GT, Wingo S, Andreansky S, Sangster MY, et al. Measuring the diaspora for virus-specific CD8+ T cells. Proc Natl Acad Sci U S A (2001) 98(11):6313-8. doi:10.1073/pnas.101132698